ClinVar Miner

Submissions for variant NM_033380.3(COL4A5):c.3148C>T (p.Pro1050Ser)

gnomAD frequency: 0.00155  dbSNP: rs143945573
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000514291 SCV000610944 likely benign not provided 2017-04-10 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000514291 SCV000841179 benign not provided 2018-02-28 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000729024 SCV000856658 benign not specified 2017-09-19 criteria provided, single submitter clinical testing
Invitae RCV000514291 SCV001101772 benign not provided 2024-01-22 criteria provided, single submitter clinical testing
GeneDx RCV000514291 SCV001851104 benign not provided 2020-07-28 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002506246 SCV002808230 likely benign X-linked Alport syndrome 2022-01-29 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003962422 SCV004781841 benign COL4A5-related condition 2020-02-05 criteria provided, single submitter clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.